Actively Recruiting
Mechanisms of Liver Fat Build-up in Obese Youth Studying NAFLD Differences Observational Study Assessing Metabolism and Liver Fat in Hispanic and Non-Hispanic Black Adolescents
Led by Yale University · Updated on 2025-01-27
260
Participants Needed
1
Research Sites
239 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Nonalcoholic fatty liver disease (NAFLD) is a common liver condition in children, especially affecting about 30% of obese youth. This research aims to understand why Hispanic obese youth are more likely to develop NAFLD compared to non-Hispanic Black (NHB) youth, who seem protected despite obesity and insulin resistance. The study explores whether differences in carbohydrate metabolism, including glycolysis, the tricyclic acid cycle, and fat production in the liver, explain the higher NAFLD risk in Hispanic youth and if these changes happen before liver fat builds up. Participants include 30 Hispanic and 30 NHB obese young people, whose carbohydrate metabolism will be measured using advanced techniques that track lactate and other metabolic processes. Additionally, 200 Hispanic obese youth without fatty liver will be followed every 12 months for two years to see if increased glycolysis comes before fat accumulation in the liver. Glucose levels will also be monitored every six months over ten days using continuous glucose monitors to understand if mild glucose changes influence these metabolic processes. During the study, participants will maintain their usual diet and physical activity while researchers assess their liver fat content and metabolism over time. The main outcome measured is lactate synthesis after 60 months. This research paused in 2022 but resumed recruitment in November 2023. Findings may offer new insights into how NAFLD develops in obese youth and inform future treatments.
CONDITIONS
Official Title
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Good general health, taking no medication on a chronic basis
- Age 12 to 18 years, in puberty (Tanner stage II-V)
- BMI greater than 85th percentile for obese cohort
You will not qualify if you...
- Baseline creatinine greater than 1.0 mg
- Pregnancy
- Presence of endocrinopathies such as Cushing syndrome
- Cardiac, pulmonary, or other significant chronic illness
- Adolescents with psychiatric disorders or substance abuse
- Monogenic obesity syndromes
- Use of drugs affecting intrahepatic fat content (e.g., liraglutide, fish oil)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06510
Actively Recruiting
Research Team
E
Ermena REFUGJATI
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here